Demand is forming right now.
Most analytics can’t see it.
Patient trajectory modeling that surfaces demand before it appears in conventional claims data — built for pharma commercial teams.
Built for three distinct commercial functions.
Each with dedicated prediction models and peer-reviewed validation.
Commercial Analytics & Market Access
Field force deployment is one of the largest line items in a brand budget — yet most targeting lists rank physicians by last year's volume. The physicians gaining momentum right now are invisible in that data.
- Physician targeting ranked by predicted future initiation — not historical volume
- Access friction signals detected before they kill a prescription
- Field deployment guided by forward-looking trajectory scores
Brand Strategy & Launch Planning
54% of launches miss first-year targets. Before your therapy has a single prescription, field force and geography decisions are made blind — based on where patients were, not where they're forming.
- Untreated-eligible patients identified before diagnosis is coded
- Emerging prescriber networks ranked by predicted future volume
- Launch territory deployment guided by forward-looking demand signals
HEOR & Medical Affairs
Closed claims carry a built-in lag of up to 6 months. Publication takes another 12–18 months. The evidence you submit to a payer may describe a market that no longer exists.
- 6 peer-reviewed publications in Nature, EP Europace, European Psychiatry, JMIR & ESC
- AUC 0.79–0.84 validated across international datasets
- Methods reproducible and publication-ready from day one
Peer-reviewed across leading journals.
See all →A prediction pipeline, not a dashboard.
Your claims data already contains the signal. SHAARPEC Foresight reads it differently — modeling how patients move through care over time and surfacing what comes next.
Purpose-built predictive models trained on your patient population. Indication-specific. Methodology transparent. Every prediction traceable to the clinical events that drove it.
The prescribers driving your next six months. The evidence your next submission will rest on. Both are identifiable today.
We start with your indication and your data question — not a generic product demo. If the signal is there, we'll show you what it looks like.
Request a Demo